Literature DB >> 1860763

Renal clearance of an ionic high-osmolar and a nonionic low-osmolar contrast medium.

H S Thomsen1, A Vestergaard, S L Nielsen, N Fogh-Andersen, K Golman, S Dorph.   

Abstract

One hundred patients with normal serum creatinine concentration underwent intravenous urography with either an ionic high-osmolar (diatrizoate) or a nonionic low-osmolar (iopamidol) contrast medium after randomization. Before injection of the contrast medium, a blood sample was drawn for determinating serum creatinine concentration, and a urine sample for measurement of urine osmolality. Using x-ray fluorescence, the plasma concentration of iodine (contrast medium) was determined on blood samples drawn approximately 3 and 4 hours after injection of the contrast medium. The glomerular filtration rate was calculated by two different formulas: one requiring only a single sample and one requiring at least two samples (standard). There were poor correlations between the standard contrast medium clearance and the serum creatinine concentration, the estimated creatinine clearance (calculated from a nomogram), as well as the urine osmolality. The 3-hour and the 4-hour single-sample values correlated well with the two-sample values for both contrast media. In patients with normal serum creatinine, the glomerular filtration rate determined by measuring the contrast medium concentration in a single plasma sample obtained at 3 hours, is almost identical to the value determined from two samples. Consequently, two samples are unnecessary.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1860763     DOI: 10.1097/00004424-199106000-00011

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  2 in total

Review 1.  An overview of the clinical pharmacokinetics of x-ray contrast media.

Authors:  M Bourin; P Jolliet; F Ballereau
Journal:  Clin Pharmacokinet       Date:  1997-03       Impact factor: 6.447

2.  Serum concentration of iopamidol after retrograde urethrography in male patients with outlet obstructive symptoms.

Authors:  I Sasagawa; M Ishigooka; T Tateno; M Tomaru; H Yanai; T Sawamura; T Nakada
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.